Jagsonpal Pharmaceuticals Limited — Important, 21-02-2025: General Updates

Jagsonpal Pharmaceuticals Limited has signed a Business Transfer Agreement to acquire the India business of Resilient Cosmeceuticals Private Limited for a cash consideration of ₹24 Crores. This strategic acquisition will be funded through internal accruals, with the company reporting a cash balance of ₹132 Crores as of December 31, 2024. This move is expected to strengthen Jagsonpal's market position in the growing segments of dermatology and gynecology, accessing a potential market opportunity of approximately ₹1,000 Crores. The acquisition will enhance Jagsonpal's presence in high-value regions such as Maharashtra, Karnataka, and Kerala while enabling deeper engagement with specialist doctors. The deal is subject to customary closing conditions and is anticipated to complete within 45 days. The Managing Director highlighted this acquisition as a significant step in driving long-term value for stakeholders, emphasizing its alignment with the company's existing portfolio.